Teresa Parent

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman Stroud, Aparna Hegde, Cynthia R. Cherry et al. · Journal of Oncology Pharmacy Practice · 2017 · 328 citations

Pharmacy, Immunology, Pharmacotherapy +17

Physical Activity Promotion Among Oncology Nurses

Kristina H. Karvinen, Sandra McGourty, Teresa Parent et al. · Cancer Nursing · 2011 · 72 citations

Medicine, Oncology, Oncology Nursing +11

Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC)

Benjamin D. Weinberg, Ron R. Allison, Cláudio H. Sibata et al. · Photodiagnosis and Photodynamic Therapy · 2009 · 54 citations

Medicine, Oncology, Treatment Planning +8

Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy

Cory Pierson, Taras Grinchak, Casey Sokolovic et al. · Radiation Oncology · 2018 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Limited-stage small cell lung cancer treated with cisplatin/irinotecan and concurrent thoracic radiation therapy.

Salini Sathya Naidu, Paul R. Walker, Teresa Parent et al. · Journal of Clinical Oncology · 2014 · 14 citations

Medicine, Oncology, Radiation Oncology +9